What’s Next for Alzheimer’s Patients?: Perspectives on the Therapeutic Market and Patient Challenges

Custom content for InCrowd by Biopharma Dive's Brand Studio

ON-DEMAND WEBINAR
Duration: 1 hour


With 10% of those over the age of 65 in the U.S. affected, the impact of Alzheimer’s disease is as profound as its cure is elusive. In a search for answers, the InCrowd team asked prescribers, nurses and caregivers their perceptions on available treatments, challenges and coping strategies.

Join us as we review the insights from this research in our latest webinar. We'll address:

  • Historical context for the therapeutic path of Alzheimer’s disease and memory impairment
  • An overview of the patient population for Alzheimer’s disease
  • Prescriber perspectives on Alzheimer’s disease treatments and expectations
  • Insights from nurses and caregivers on daily challenges and the human toll of the condition

SPEAKERS  

Diane Hayes, PhD
President and Co-Founder
InCrowd


Molly Simpson
Director of Client Engagement,
InCrowd

WATCH NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2019 Industry Dive